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Xenobiotic estrogens are external compounds with estrogenic activity that may thereby affect the risk of breast cancer. This paper describes a
mechanism by which xenoestrogens may affect the development of breast cancer. Estradiol metabolism proceeds by hydroxylation at one of two
mutually exclusive sites at C-2 and C-16a. The catechol pathway yields the weakly estrogenic 2-hydroxyestrone (2-OHEl), which inhibits breast cell
proliferation. In contrast, the alternative pathway yields the genotoxic 16a-hydroxyestrone (16cx-OHE1), which enhances breast cell growth,
increases unscheduled DNA synthesis, and oncogene and virus expression, and increases anchorage-independent growth. Using a radiometric
assay that measures the relative formation of 16a-OHE, versus 2-OHE, from specifically tritiated estradiol in (ER+) MCF-7 cells, we compared the
ratio of 16a-OHE1/2-OHEl observed after treatment with the known rodent carcinogen 7,12-dimethylbenz[a]anthracene (DMBA) with the ratios after
treatment with DDT, atrazine, y-benzene hexachloride, kepone, coplanar PCBs, endosulfans and 11, linoleic and eicosapentenoic acids, and
indole-3-carbinol (13C). These pesticides significantly increase the ratio of 16ct-OHE1/2-OHE, metabolites to values comparable to or greater than
those observed after DMBA. In contrast, the antitumor agent 13C increased 2-OHE, formation and yielded ratios that are 1/3 of those found in
unexposed control cells and 1/10th of those found in DMBA-treated cells. Thus the ratio of 16a-OHEl/2-OHEl may provide a marker for the risk of
breast cancer. Assays of this ratio, which can be measured in spot urines, may prove useful for a variety of in vitro and in vivo studies bearing on
breast cancer risk. - Environ Health Perspect 103(Suppl 7):147-150 (1995)
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Introduction
Changes in screening practices or in known
or suspected risk factors cannot completely
account for recently observed increases in
the incidence ofbreast, prostate, and testic-
ular cancer or suspected increases in male
and female reproductive disorders, such as
reduced sperm count, increased reproduc-
tive failures, endometriosis, and ovarian
fibroid tumors. With respect to breast can-
cer, most of the known risk factors for the
disease other than genetic makeup can be
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related to cumulative lifetime exposure to
estrogen (1,2).
We have recently hypothesized that for-
eign compounds with estrogenic activity
can affect the risk of breast cancer (3).
Estradiol metabolism predominantly pro-
ceeds via two mutually exclusive pathways:
one pathway yields the catechol estrogen 2-
hydroxyestrone (2-OHE1), which is weakly
antiestrogenic and nongenotoxic (4); the
alternative pathway yields 16x-hydroxy-
estrone (16a-OHEI), a fully potent estro-
gen, which is tumorigenic and genotoxic
and causes increased cell proliferation
(Figure 1) (5). The reasons for suspecting
that alterations in endocrine function
underlie estrogen-mediated cancers, such as
those ofthe breast and endometrium, have
evolved from diverse observations in
endocrinology, biochemistry, and epidemi-
ology. Some 30 years ago, it was calculated
that on a molar basis 2-OHE1 possessed
about 0.25% ofthe uterotrophic activity of
estradiol (6). Indeed, some studies suggest
that 2-OHE1 is a weak antiestrogen (7,8).
Others have noted that 4-OHE2 is carcino-
genic in the Syrian hamster kidney model
where it is a major metabolite (9), but it is
a minor metabolite in people. In contrast,
16a-OHEI covalently binds with estrogen
receptors and amino functions on DNA
(10,11) and exerts persistent biological
responses (12). A number of lines of evi-
dence suggest that 16a-hydroxylation is a
biological marker of risk for breast cancer
and may directly contribute to the initia-
tion and progression of the disease.
16a-OHEI, the product of the 16a-
hydroxylation pathway of E2 metabolism,
causes prolonged growth responses by
virtue ofits ability to bind covalently to the
estrogen receptor (10). This paper presents
results of an established assay of estradiol
metabolism applied to a number oforgano-
chlorine pesticides. Materials that increase
the ratio of16ix-OHEI/2-OHE, should be
regarded aspotential breastcarcinogens.
Methods
Estradiol metabolism via the C-2 and C-
16a hydroxylation pathways was assayed
radiometrically (13). We measured the
amount of estradiol metabolized by these
two pathways in estrogen receptor positive
(ER+) human breast cell cultures (MCF-7)
in the presence and absence of 7,12-
dimethylbenz[a]anthracene (DMBA) and
linoleic acid as positive tumorigenic
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Figure 1. Metabolic pattern for estrogen metabolism pathway yields the catechol estrogen antagonist 2-hydroxy-
estrone (2-OHE,), which is rapidly converted to 2-methoxyestrone; pathway 11 yields the estrogen agonist
16a-hydroxyestrone(16a-OHE,), which is ultimately converted to estriol.
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Figure 2. Effect of pesticides on C-2 hydroxylation of
estradiol in MCF-7 cells. Abbreviations: ES1,
Endosulfan 1; ES2, Endosulfan 2; y-BHC, y-benzene
hexachloride. Percent of C-2 estradiol hydroxylation
induced in MCF-7 cells per million cells. Assay incuba-
tion was carried out for 48 hr. Mean values are aver-
ages oftriplicates from three experiments.
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O- controls, indole-3-carbinol and eicosapen-
tenoic acid as negative (antitumor) con-
trols, and a variety of chlorinated
pesticides. The MCF-7 cells were plated at
a density of 105 cells per milliliter in
MEM + 10% FBS into 24-well plates and
underwent an attachment period of 24 hr.
After 24 hr the medium was aspirated from
the wells and replaced with fresh medium
containing 10-5 M ofthe various pesticides
and either C-2 or C-16a tritiated estradiol
at a concentration of 10-7 M. The cells
were then incubated for a further 48 hr. At
the end ofthe incubation period, 0.1 ml of
the medium in each well was aliquoted
into counting vials containing 5 ml ofscin-
tillant, which were counted in a Packard
300 counter. An additional 0.5 ml of the
medium was diluted with 3 ml of distilled
water and lyophilized to separate the triti-
ated water (3H20) from the residual
bound label. One-milliliter aliquots of the
sublimed water were counted in duplicate.
From the relative amount oftritiated water
formed, the extent of conversion of E2 to
2-OHE1 and 16a-OHEI, respectively, can
be calculated. In addition, the cells were
washed with buffer to remove residual pro-
tein and were then analyzed for DNA. The
data in the figures are expressed as the per-
cent conversion of the tracer to the two
metabolites (Figures 2 and 3) and the ratio
of C-16a/C-2 hydroxylation, with the
ratio for the unexposed control cells set
equal to 1 (Figure 4).
Results
All of the organochlorine pesticides tested
in the present study decreased the amount
of2-hydroxyestrone formed (Figure 2) and
significantly increased the amount of 16a-
hydroxyestrone formed (Figure 3) relative
to untreated control cells by 3- to 4-fold.
The greatest effects were observed with
DDT, o,p-DDE, kepone, and atrazine,
which caused substantially greater conver-
sion to 16a-OHE, and lower conversion
to 2-OHE1 than was observed with
DMBA, a known carcinogen. The exact
extent of the change in the metabolic pat-
tern varied with the structure of the com-
pound being tested. The DDT-related
compounds had the greatest potency. The
combined effect of the changes in both
reactions is shown in Figure 4, which
shows the change in the ratio ofC-16a/C-
2 metabolites in response to the various
compounds that were tested.
The chlorinated pesticides that we have
tested greatly increased the ratio of C-
16a/C-2 metabolites relative to the ratio in
the untreated control breast cancer cell cul-
tures. Other compounds, such as indole-3-
carbinol and eicosapentenoic acid, reduced
the ratio to levels lower than those that
occurred in unexposed control cells. In
3EC e;.l) cL i.3 cocL n -C
o 4e i 0 -c.
Figure 3. Effect of pesticides on C-16a-hydroxylation
of estradiol in MCF-7 cells. Percent of C-16a-hydroxy-
lation per million cells. Assay incubation was carried
out for 48 hr. Mean values are averages of triplicates
from three experiments.
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Figure 4. Effect of pesticides on the 16cx/2 estrogen
metabolite ratio. (Calculated from mean values, Figures
2and3.)
general, these organochlorine pesticides
produced increases in 16a-OHE1 compa-
rable to or severalfold greater than that
produced by the positive control com-
pound, DMBA. Atrazine and DDE appear
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to be 3 to 4 times more potent inducers of
16Q-OHE, than DMBA. 13C and eicos-
apentenoic acid indirectly inhibited
16a-OHEI formation by substantially
increasing C-2-hydroxylation, yielding
ratios that were 1/10 and 1/2 that of
DMBA, respectively.
Discussion
A number ofcommon organochlorine pes-
ticides alter estrogen metabolism in ER+
cell cultures by increasing the production of
the estrogen agonist 16a-OHE, and reduc-
ing that of the weak antagonist 2-OHE1.
When compared with the ability ofDMBA
or linoleic acid (14,15) to increase 16a-
OHEI, the pesticides tested appear to have
similar or greater activity. Previous studies
(5) have demonstrated that 16a-OHE, is
genotoxic to normal mammary epithelium
and that an elevated ratio of 16a/2 is asso-
ciated with breast and other cancers in ani-
mals. 16a-OHE, increases unscheduled
DNA synthesis, hyperproliferation, and
increased anchorage-independent growth.
In contrast, the alternative metabolite
2-OHE1, which exhibits none ofthe above
properties (4), appears to be weakly anti-
estrogenic (7,8). In addition, in vivo and in
vitro studies with carcinogens, oncogenes,
and tumor viruses have also produced
between 10- and 200-fold higher levels of
16a-OHE, compared to unexposed con-
trols (16,17). Fifty percent elevated levels
of 16a-hydroxylation have been found in
human breast cancer as compared to con-
trol cases (18). Imoto (19) has recently
reported a major increase in the C-16a/C-2
metabolite ratio in the metabolites isolated
by HPLC directly from tumor tissue com-
pared to normal control tissue. The C-
16a/C-2 urinary metabolite ratio in women
with carcinoma in situ in the cervix and in
control subjects also differed significantly
(p= 0.008) (20). There is general agree-
ment that most known risk factors for
breast cancer can be tied to total lifetime
exposures to estrogens (1,2). Our findings,
and those ofother researchers, indicate that
a number ofenvironmental chemicals affect
endogenous hormone production and
metabolism. Other studies have indicated
that an elevated ratio of 16a-OHEI/2-
OHE, is associated with a number oftoxic
processes. Our results indicate that materi-
als such as the organochlorine pesticides
tested here may increase the risk of breast
cancer by altering that ratio. The higher
the ratio, the greater the effect on breast
cancer cell proliferation, development, and
promotion.
Despite this evidence, some have argued
that the catechol estrogens play an impor-
tant role in producing cancer (21). They
maintain that the catechol estrogens form
quinones and semiquinones, which can
form adducts with DNA and which may
serve as the initiating events that lead to
cancer. These researchers have tended to
lump all catechol estrogens together as a
class; these include: 4-hydroxyestradiol,
2-hydroxyestradiol, and 2-hydroxyestrone.
The former two have hydroxy groups at the
17 position, while the latter has a ketone at
this same position.
In fact, the three common catechol
estrogens have distinctly different proper-
ties. Recently, some researchers (22) have
shown that only 4-hydroxyestradiol is car-
cinogenic and only in the rather unique
male Syrian hamster kidney model. There
is no evidence that this compound is even
formed in humans in vivo. Moreover, no
human or animal evidence indicates that
carcinogenic effects arise from the catechol
estrogen, 2-OHEI, and it does not show
any ofthe genotoxic or proliferative effects
that have been associated with 16a-
hydroxyestrone. Recent dietary studies fur-
ther strengthen the case for concluding
that 2-hydroxyestrone is protective against
both breast and colon cancer. Both human
and animal in vivo studies have found that
diets high in materials that stimulate
2-OHE1 are protective against cancer.
Animal studies from three laboratories have
shown that induction of 2-hydroxylation
with indole-3-carbinol results in a decrease
in tumor formation (23-26). Rates of
these two cancers were inversely related to
estimated cabbage consumption in 27
European countries (L Kohlmeier, private
communication). It is well known that
diets high in cabbage and other cruciferae
induce P450 lAl and 1A2, which carry
out 2-hydroxylation of estradiol. Under
these conditions, there is no induction of
4-hydroxylation (27). Further support for
this protective effect in humans comes
from recent observations from this labora-
tory on patients with laryngeal papillomas.
Consumption of foods that induce estra-
diol 2-hydroxylation have markedly
reduced the rate of growth and recurrence
of laryngeal tumors in more than 20
patients observed to date.
Thus, it is important to realize that not
all catechol estrogens have similar biological
properties. The one form ofcatechol estro-
gens that appears to be carcinogenic in the
male Syrian hamster kidney model has not
been shown to circulate in humans. For all
of these reasons, we believe that 2-OHE1
plays a protective, rather than a harmful,
role for human cancer development. We
recognize that the relative importance of
specific estradiol metabolites and pathways
will ultimately be determined by continued
laboratory investigations. However, one
point on which all investigators agree at this
time is that the greater the lifetime exposure
to estradiol, the greater the riskofdeveloping
breast cancer.
Some recent epidemiologic studies have
found that higher serum levels of organo-
chlorines are tied to a 4-fold increase in
breast cancer (28-30). One study on this
point was negative (31), but in this study
there were equal groups of Asian,
African-American, and Caucasian women.
Estradiol metabolism appears to be differ-
ent in Asian women than in white and
black women (32). When the 150 Asian,
white, and African-American breast cancer
cases in this negative study were analyzed as
three distinct racial/ethnic groups, black
women and white women had higher
organochlorine levels and 2 to 3 times more
breast cancer. Asians showed no effect, con-
sistent with other observations that they
may have dietary or genetic protective fac-
tors (33). Our assay suggests that these
same materials that have been associated
with increased breast cancer in women also
alter estradiol metabolism by increasing the
ratio of16a-OHEI/2-OHEI. Thus an ele-
vated ratio constitutes a biological marker
for the riskofbreast cancer.
Assays of this ratio, which can be
efficiently measured in urine, may prove
useful for screening new chemicals for their
potential risk for breast cancer and for
prognostic indices, developing and testing
new cancer chemotherapies for breast can-
cer patients and those at elevated risk, and
generating preventive nutritional strategies
and interventions.
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